2024

• patent2024/07/24

  The Israel Patent Office (ILPO) Grants AskAt a Patent for AAT-730 Salt & Crystal Forms

  AskAt received a Notice before Acceptance dated July 1, 2024 from the Israel Patent Office (ILPO) for a salt and crystal forms patent for its CB2 agonist, AAT-730. The notice was issued in connection with Application Number 301333 (Filing Date: November 11, 2021).

• patent2024/07/05

  AskAt Receives Salt & Crystal Forms Patent for AAT-730 from the Intellectual Property Office of New Zealand (IPONZ)

  The Intellectual Property Office of New Zealand (IPONZ) granted AskAt a Notice of Acceptance for a salt and crystal forms patent, dated June 24, 2024 for its CB2 agonist, AAT-730. The notice was issued in connection with Application Number 797451 (Filing Date: November 11, 2021).

• patent2024/06/11

  Intellectual Property India Grants AskAt a Patent for AAT-076 Production Process

  AskAt received a Letters Patent dated May 28, 2024 for a process for the differential solubility-driven asymmetric transformation of substituted 2H-chromene-3-carboxylic acids (Patent Number: 539578). The Notice was issued by the Office of the Controller General of Patents, Designs & Trade Marks (CGPDTM) in connection with Indian Patent Application No. 202127037497 (Filing Date: January 20, 2020).

• patent2024/04/16

  CB2 agonist (AAT-730) Salt & Crystal Forms Patent Registered in the U.S.

  AskAt received an Issue Notification from the U.S. Patent and Trademark Office (USPTO) dated April 23, 2024 for a salt and crystal forms patent for the company’s CB2 agonist, AAT-730 (Patent Number: 11,964,963). The Notification was issued in connection with Application Number 18/035,195 (Filing Date: November 11, 2021).

• patent2024/04/16

  Brazil’s National Institute of Industrial Property (Instituto Nacional da Propriedade Industrial: INPI) Grants AskAt a Patent for AAT-730 Salt & Crystal Forms

  AskAt received a Notice of Allowance for a salt and crystal forms patent for the company’s CB2 agonist, AAT-730. Application No. BR 11 2023 003811-1 (Filing Date: November 11, 2021) was published in the Brazilian Industrial Property Journal (Official Gazette) No: 2777 on March 26, 2024.

• ir2024/03/29

  11th Fiscal Year Announcement of Financial Results

  11th Fiscal Year Announcement of Financial Results

• patent2024/02/13

  China National Intellectual Property Administration Grants AskAt a Patent for AAT-730 Salt & Crystal Forms

  AskAt received a Notice of Allowance dated February 4, 2024 from the China National Intellectual Property Administration (CNIPA) for a salt and crystal forms patent for the company’s CB2 agonist, AAT-730. The notice was issued in connection with Chinese Patent Application No. 202180063678.2 (Filing Date: November 11, 2021).

• patent2024/02/02

  Canadian Intellectual Property Office Grants AskAt a Patent for AAT-730 Salt & Crystal Forms

  AskAt received a Notice of Allowance dated January 25, 2024 from the Canadian Intellectual Property Office (CIPO) for a salt and crystal forms patent for the company’s CB2 agonist, AAT-730. The notice was issued in connection with Canadian Patent Application No. 3,196,706 (Filing Date: November 11, 2021).

• patent2024/02/01

  Korean Intellectual Property Office Grants AskAt a Patent for AAT-730 Salt & Crystal Forms

  AskAt received a Notice of Allowance dated January 24, 2024 from the Korean Intellectual Property Office (KIPO) for a salt and crystal forms patent for the company’s CB2 agonist, AAT-730. The notice was issued in connection with Korean Patent Application No. 10-2023-7017249 (Filing Date: November 11, 2021).

• patent2024/01/26

  Intellectual Property India Grants AskAt a Patent for the Use of EP4 Receptor Antagonists in the Treatment of NASH-Associated Liver Cancer

  AskAt received a Letters Patent dated January 4, 2024 for a use patent for its EP4 receptor antagonist in the treatment of NASH-associated liver cancer. The Notice was issued by the Office of the Controller General of Patents, Designs & Trade Marks (CGPDTM) in connection with Indian Patent Application No. 201827020731.0 (Filing Date: November 2, 2017).

• patent2024/01/17

  Intellectual Property India Grants AskAt a Patent for AAT-076 Formulation

  AskAt received a Letters Patent dated December 14, 2023 for a formulation patent for AAT-076, its COX-2 inhibitor. The Notice was issued by the Office of the Controller General of Patents, Designs & Trade Marks (CGPDTM） in connection with Indian Patent Application No. 641/MUMNP/2014 (Filing Date: October 18, 2012).

• patent2024/01/17

  Japan Patent Office Grants AskAt a Patent for the AAT-730 Salt & Crystal

  AskAt received an Official Decision of Grant from the Japan Patent Office dated January 9, 2024 for a salt and crystal forms patent for the company’s CB2 agonist, AAT-730. The notice was issued in connection with Japanese Patent Application No. 2023-528364 (Filing Date: November 11, 2021).